These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1394227)

  • 41. Opposing effects of fibrosarcoma cell-derived IL-1 alpha and IL-1 beta on immune response induction.
    Marhaba R; Nazarenko I; Knöfler D; Reich E; Voronov E; Vitacolonna M; Hildebrand D; Elter E; Apte RN; Zöller M
    Int J Cancer; 2008 Jul; 123(1):134-45. PubMed ID: 18412246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human lung tumor cell secretion of interleukin-2 for protection against tumor engraftment.
    Alosco T; Gansbacher B; Bankert R; Takita H; Petrelli N
    Ann Surg Oncol; 1994 May; 1(3):229-35. PubMed ID: 7842293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene.
    Dong Z; Juang SH; Kumar R; Eue I; Xie K; Bielenberg D; Lu W; Bucana C; Yang X; Fidler IJ
    Cancer Immunol Immunother; 1998 May; 46(3):137-46. PubMed ID: 9625537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the potential therapeutic effects of interleukin 2 or interleukin 4 secretion by a single tumour.
    Patel PM; Flemming CL; Russell SJ; McKay IA; MacLennan KA; Box GM; Eccles SA; Collins MK
    Br J Cancer; 1993 Aug; 68(2):295-302. PubMed ID: 8347485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retroviral-mediated IL-2 gene transfer into murine neuroblastoma.
    Cho HS; Song JY; Park CY; Lyu CJ; Kim BS; Kim KY
    Yonsei Med J; 2000 Feb; 41(1):76-81. PubMed ID: 10731923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.
    Song X; Voronov E; Dvorkin T; Fima E; Cagnano E; Benharroch D; Shendler Y; Bjorkdahl O; Segal S; Dinarello CA; Apte RN
    J Immunol; 2003 Dec; 171(12):6448-56. PubMed ID: 14662844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 48. Immune selection in murine tumors. A study of MCA induced sarcomas in normal and immunodeficient mice.
    Engel AM; Svane IM; Rygaard J; Werdelin O
    Folia Microbiol (Praha); 1998; 43(5):483-6. PubMed ID: 9821304
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of splenectomy on fibrosarcoma "metastases" in lungs of mice.
    Milas L; Mujagic H
    Int J Cancer; 1973 Jan; 11(1):186-90. PubMed ID: 4790835
    [No Abstract]   [Full Text] [Related]  

  • 50. Murine colon carcinoma cells engineered to produce human interleukin-2 induce tumor-specific anti-tumor response.
    Gunji Y; Tagawa M; Matsubara H; Takenaga K; Shimada H; Kondo F; Suzuki T; Nakajima K; Aoki T; Asano T; Ochiai T; Isono K; Kageyama H; Nakamura Y; Sakiyama S
    Int J Cancer; 1996 Mar; 66(1):135-9. PubMed ID: 8608957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer.
    Douvdevani A; Huleihel M; Zöller M; Segal S; Apte RN
    Int J Cancer; 1992 Jul; 51(5):822-30. PubMed ID: 1612788
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model.
    Abdel-Wahab Z; Li WP; Osanto S; Darrow TL; Hessling J; Vervaert CE; Burrascano M; Barber J; Seigler HF
    Cell Immunol; 1994 Nov; 159(1):26-39. PubMed ID: 7954840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effect of locally produced and exogenous interleukin-6 on tumor growth in vivo.
    Dougherty GJ; Thacker JD; Lavey RS; Belldegrun A; McBride WH
    Cancer Immunol Immunother; 1994 May; 38(5):339-45. PubMed ID: 8162616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicity.
    Apte RN; Douvdevani A; Zoller M; White RM; Dvorkin T; Shimoni N; Fima E; Hacham M; Huleihel M; Benharroch D
    Immunol Lett; 1993 Dec; 39(1):45-52. PubMed ID: 8144190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Constitutive expression of interleukin-8 by Mutatect cells markedly affects their tumor biology.
    Haqqani AS; Sandhu JK; Birnboim HC
    Carcinogenesis; 2001 Feb; 22(2):243-50. PubMed ID: 11181444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor.
    Karp SE; Farber A; Salo JC; Hwu P; Jaffe G; Asher AL; Shiloni E; Restifo NP; Mulé JJ; Rosenberg SA
    J Immunol; 1993 Feb; 150(3):896-908. PubMed ID: 8423345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carcinogenesis in tissue culture 25: reduced tumorigenicity of alkaline phosphatase-constitutive variants from Chinese hamster ovary cells.
    Nose K; Sakakibara K
    Jpn J Exp Med; 1975 Oct; 45(5):327-34. PubMed ID: 1083437
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and characterization of an interleukin-2-transduced human ovarian carcinoma tumor vaccine not expressing major histocompatibility complex molecules.
    Santin AD; Ioli GR; Hiserodt JC; Manetta A; Pecorelli S; DiSaia PJ; Granger GA
    Am J Obstet Gynecol; 1996 Feb; 174(2):633-40. PubMed ID: 8623798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-K-ras overexpression is characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma.
    Algarra I; Perez M; Serrano MJ; Garrido F; Gaforio JJ
    Invasion Metastasis; 1998-1999; 18(5-6):261-70. PubMed ID: 10729771
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Manipulation of metastasis and tumour growth by transfection with histocompatibility class I genes.
    Hämmerling GJ; Klar D; Katzav S; Segal S; Feldman M; Wallich R; Hämmerling A
    J Immunogenet; 1986; 13(2-3):153-7. PubMed ID: 3819449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.